|
Name |
enellin-N-(4-O-methyl)-β-D-glucopyranoside
|
Molecular Formula | C28H35NO10 | |
IUPAC Name* |
1-[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy-5-(4,6-dimethylocta-2,4-dienoyl)-4-hydroxy-3-(4-hydroxyphenyl)pyridin-2-one
|
|
SMILES |
CCC(C)C=C(C)C=CC(=O)c1cn(OC2OC(CO)C(OC)C(O)C2O)c(=O)c(-c2ccc(O)cc2)c1O
|
|
InChI |
InChI=1S/C28H35NO10/c1-5-15(2)12-16(3)6-11-20(32)19-13-29(27(36)22(23(19)33)17-7-9-18(31)10-8-17)39-28-25(35)24(34)26(37-4)21(14-30)38-28/h6-13,15,21,24-26,28,30-31,33-35H,5,14H2,1-4H3/b11-6+,16-12+/t15-,21-,24-,25-,26-,28+/m1/s1
|
|
InChIKey |
ZCRWBZMWDINYNN-SZKWZXLKSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 545.59 | ALogp: | 1.5 |
HBD: | 5 | HBA: | 11 |
Rotatable Bonds: | 10 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 167.9 | Aromatic Rings: | 3 |
Heavy Atoms: | 39 | QED Weighted: | 0.169 |
Caco-2 Permeability: | -5.455 | MDCK Permeability: | 0.00000364 |
Pgp-inhibitor: | 0.025 | Pgp-substrate: | 0.962 |
Human Intestinal Absorption (HIA): | 0.958 | 20% Bioavailability (F20%): | 0.011 |
30% Bioavailability (F30%): | 0.887 |
Blood-Brain-Barrier Penetration (BBB): | 0.155 | Plasma Protein Binding (PPB): | 90.72% |
Volume Distribution (VD): | 0.676 | Fu: | 7.62% |
CYP1A2-inhibitor: | 0.026 | CYP1A2-substrate: | 0.091 |
CYP2C19-inhibitor: | 0.029 | CYP2C19-substrate: | 0.179 |
CYP2C9-inhibitor: | 0.022 | CYP2C9-substrate: | 0.608 |
CYP2D6-inhibitor: | 0.014 | CYP2D6-substrate: | 0.258 |
CYP3A4-inhibitor: | 0.071 | CYP3A4-substrate: | 0.176 |
Clearance (CL): | 1.45 | Half-life (T1/2): | 0.474 |
hERG Blockers: | 0.034 | Human Hepatotoxicity (H-HT): | 0.274 |
Drug-inuced Liver Injury (DILI): | 0.776 | AMES Toxicity: | 0.111 |
Rat Oral Acute Toxicity: | 0.081 | Maximum Recommended Daily Dose: | 0.344 |
Skin Sensitization: | 0.061 | Carcinogencity: | 0.301 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.006 |
Respiratory Toxicity: | 0.025 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005615 | 0.395 | D06BQU | 0.268 | ||||
ENC002582 | 0.367 | D0Q0PR | 0.264 | ||||
ENC004475 | 0.362 | D08DFX | 0.261 | ||||
ENC003476 | 0.361 | D01TNW | 0.260 | ||||
ENC003004 | 0.361 | D0T5XN | 0.253 | ||||
ENC004476 | 0.357 | D0TC7C | 0.246 | ||||
ENC004958 | 0.352 | D0I9HF | 0.244 | ||||
ENC004073 | 0.331 | D0AZ8C | 0.244 | ||||
ENC004802 | 0.328 | D0C9XJ | 0.240 | ||||
ENC005772 | 0.328 | D07VLY | 0.240 |